Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,842 | -27,183 | -15,586 | -161,354 | -142,760 |
| Depreciation Amortization | 1,773 | 1,182 | 576 | 24,913 | 24,593 |
| Accounts receivable | 4,783 | 4,895 | 4,737 | -809 | -13,003 |
| Accounts payable and accrued liabilities | -5,448 | -6,026 | -4,317 | -3,160 | 3,050 |
| Other Working Capital | -4,803 | -154 | 2,985 | -2,703 | 744 |
| Other Operating Activity | 11,761 | 9,660 | 4,800 | 46,668 | 51,321 |
| Operating Cash Flow | $-29,776 | $-17,626 | $-6,805 | $-96,445 | $-76,055 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -445 | -141 | -124 | -1,613 | -1,347 |
| Net Acquisitions | N/A | N/A | N/A | 34,186 | N/A |
| Purchase Of Investment | -39,898 | -27,139 | -8,869 | -137,385 | -121,303 |
| Sale Of Investment | 49,035 | 30,735 | 22,935 | 210,491 | 171,891 |
| Investing Cash Flow | $8,692 | $3,455 | $13,942 | $105,679 | $49,241 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,913 | 10,913 | 10,950 | N/A | N/A |
| Debt Repayment | -128 | -92 | -57 | -30,523 | -392 |
| Common Stock Issued | N/A | N/A | 25 | 207 | 85 |
| Other Financing Activity | -242 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $10,543 | $10,821 | $10,918 | $-30,316 | $-307 |
| Beginning Cash Position | 35,937 | 35,937 | 35,937 | 57,019 | 57,019 |
| End Cash Position | 25,396 | 32,587 | 53,992 | 35,937 | 29,898 |
| Net Cash Flow | $-10,541 | $-3,350 | $18,055 | $-21,082 | $-27,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,776 | -17,626 | -6,805 | -96,445 | -76,055 |
| Capital Expenditure | -445 | -141 | -124 | -1,613 | -1,347 |
| Free Cash Flow | -30,221 | -17,767 | -6,929 | -98,058 | -77,402 |